retatrutide phase 2 trial type 2 diabetes results 2024 2025 The Effect of on Kidney Parameters in Participants With Mellitus and/or Obesity 🚨Breaking: Phase III retatrutide study demonstrates – Endocrinology Archives - Drug Discovery

Do I need dose adjustments if I have kidney problems

Nat Commun 15(1):5912 Mosterd CM, Bjornstad P, van Raalte DH (2020) Nephroprotective effects of GLP-1 receptor agonists: where do we stand

Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice

Additional Benefits: Reduced craving for food, decreased addictive behaviors, a significant reduction in major cardiac events (27% reduction in fatal heart attacks), 7% reduction in stroke, decreased occurrence of obesity-related cancers, improved fertility in both men and women, reduced heart failure rates, and increased survival in heart failure patients